1. Nakayama, Kentaro, Rahman, Munmun, Rahman, Mohammed Tanjimur, Ishikawa, Noriyuki, Kyo, Satoru. 2017. Nucleus accumbens-1/GADD45GIP1 axis mediates cisplatin resistance through cellular senescence in ovarian cancer. In Oncology letters, 13, 4713-4719. doi:10.3892/ol.2017.6099. https://pubmed.ncbi.nlm.nih.gov/28599472/
2. Lim, Su Jun, Scott, Anthony, Xiong, Xiao-Peng, Zhou, Rui, Li, Willis X. . Requirement for CRIF1 in RNA interference and Dicer-2 stability. In RNA biology, 11, 1171-9. doi:10.4161/rna.34381. https://pubmed.ncbi.nlm.nih.gov/25483042/
3. Zhang, Qing, Deng, Zhiping, Yang, Yongkun. 2023. Metastasis-Related Signature for Clinically Predicting Prognosis and Tumor Immune Microenvironment of Osteosarcoma Patients. In Molecular biotechnology, 65, 1836-1845. doi:10.1007/s12033-023-00681-7. https://pubmed.ncbi.nlm.nih.gov/36807122/
4. Nishi, Takeshi, Maruyama, Riruke, Urano, Takeshi, Tanaka, Tsuneo, Tajima, Yoshitsugu. . Low expression of nucleus accumbens-associated protein 1 predicts poor prognosis for patients with pancreatic ductal adenocarcinoma. In Pathology international, 62, 802-10. doi:10.1111/pin.12020. https://pubmed.ncbi.nlm.nih.gov/23252869/
5. Wang, Qi, Xie, Zhuolin, Li, Chang, Wei, Tengteng, Zhao, Jun. 2022. CRIF1 promotes the progression of non-small-cell lung cancer by SIRT3- mediated deacetylation of PYCR1. In Journal of molecular histology, 53, 657-667. doi:10.1007/s10735-022-10075-9. https://pubmed.ncbi.nlm.nih.gov/35716330/